SavedAdd your journal

Journals / Toplum ve Hekim / 2012 / Cilt: 27 - Sayı: 2

Human Papilloma virus vaccines and an evaluation as regard the view of Turkey

"Demokrat" hastalığa karşı Aşılar: Rotavirus aşıları

Sema ÇAVUŞ ALP
Saliha ALTIPARMAK
Pages
143–160
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

World Health Organization recommended that rotavirus vaccine for infants should be included in all national immunization programmes, but many scientific, programmatic, and financial challenges face the global use of the vaccines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Rotavirus is the most common cause of severe diarrhoea in children worldwide and diarrhoeal deaths in children in developing countries.
📊
Key Findings & Data:Efficacy of these vaccines has ranged from 80% to 98% in industrialized countries, including Latin America, and 39% to 77% in developing countries, such as Africa and Asia.
💡
Conclusion & Impact:World Health Organization recommended that rotavirus vaccine for infants should be included in all national immunization programmes, but many scientific, programmatic, and financial challenges face the global use of the vaccines.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Rotavirus is the most common cause of severe diarrhoea in children worldwide and diarrhoeal deaths in children in developing countries. Two live oral rotavirus vaccines have been licensed in many countries. Efficacy of these vaccines has ranged from 80% to 98% in industrialized countries, including Latin America, and 39% to 77% in developing countries, such as Africa and Asia. World Health Organization recommended that rotavirus vaccine for infants should be included in all national immunization programmes, but many scientific, programmatic, and financial challenges face the global use of the vaccines.

Özet

Rotavirus tüm dünyada çocukluk çağı ishallerinin ve gelişmekte olan ülkelerde ishale bağlı ölümlerin en sık görülen etkenidir. Halen kullanımda olan iki canlı zayıflatılmış oral rotavirus aşısı pekçok ülkede ruhsatlandırılmıştır. Aşıların etkinliği gelişmiş ülkeler ve Latin Amerika'da %80-98, Afrika ve Asya'daki gelişmekte olan ülkelerde %39-77'dir. Dünya Sağlık Örgütü bu aşıların tüm dünya çocukları için ulusal bağışıklama programına eklenmesini önermektedir. Ancak global kullanımlarına ilişkin biyolojik, finansal, lojistik sorunlar mevcuttur.

🔖

Cite This Article

ALP, S. Ç., ALTIPARMAK, S. (2012). Human Papilloma virus vaccines and an evaluation as regard the view of Turkey. Toplum ve Hekim, Cilt: 27 - Sayı: 2, 143–160. https://ajindex.com/articles/367703

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Altındiş M, Yavru S, Şimşek A, Özkul A, Çeri A, Koç H. (2004) Rotavirus infection in children with acute diarrhea as detected by latex agglutination, ELISAand polyacrylamide gel electrophoresis. Indian Pediatr. 41:590-594
  2. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. (2010) Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet; 376:606-14
  3. Bishop RF, Davidson GP, Holmes IH. (1974) Dedection of a new virus by electron microscopy of fecal extracts from children with acute gastroenteritis. Lancet. 1:149-151.
  4. Blutt, SE, Conner ME. (2007). Rotavirus: to the gut and beyond. CurrOpin Gastroenterol.23:39-43.
  5. Bozdayi G, Dogan B, Dalgic B, Bostanci I, Sari S, Battaloglu NO, Rota S, Dallar Y, Nishizono A, Nakagomi O, Ahmed K. (2008) Diversity of human rotavirus G9 among children in Turkey. J Med Virol; 80(4):733-40 CDC (Centers for Disease Control and Prevention). (2006) Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR.;55(RR-12):1-16 CDC (1999-a) Rotavirus vaccine for prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48(RR-2):1 -20. CDC (1999-b) Intussusception among recipients of rotavirus vaccine-United States,1998-1999. Morb Mortal Wkly Rep,48(27):577-81.
  6. Ceyhan M, Kanra G,Yeniay I, Ciliv G,Vesikari T. (1987) Rotaviruses in infants with diarhea studied by viral RNA elektrophoresis in Ankara, Turkey Turk J Pediatr. 29:145-149.
  7. Ceyhan M, Alhan E, Salman N, Kurugöl Z, Yıldırım I, Celik U, et al. (2009) Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: A hospital-based study. J Infect Dis;200 (supll 1 ):S234-8. Chen S-C, Tan L-B, Huang L-M Chen K-T. (2012) Rotavirus infection and the current satatus of rotavirus vaccines. Journal of Formosan Medical Association. 111,183-92.
  8. Clark HF, Offit PA, Parashar UD, Ward RL. (2008) Rotavirus vaccines, in Plotkin S, Orenstein W, Offit P (Eds). Vaccines (5th ed) Elsevier Inc, UK. Cunliffe N, Nakagomi O. (2007) Introduction of rotavirus vaccines in developing countries:remaining challenges. Annals of Tropical Pediatrics;27:157-67.
  9. Çataloluk O, Itturiza M, Gray J. (2005) Molecular characterization of rotaviruses circula